Superior clinical, endoscopic and histologic efficacy and tolerability of pantoprazole compared with ranitidine and omeprazole in patinets with gastro-esophageal reflux disease (GORD) (CROSBI ID 512700)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Pulanić, Roland ; Premužić, Marina ; Brkić, Tomislav ; Opačić, Milorad ; Jokić-Begić, Nataša
engleski
Superior clinical, endoscopic and histologic efficacy and tolerability of pantoprazole compared with ranitidine and omeprazole in patinets with gastro-esophageal reflux disease (GORD)
Pharmacologycal, acid-suppressing therapy with standard doses of PPI has markedly improved the outcome of GORD. Pantoprasole has significantly better resultsthan omeprasole, it is highly effectice and well tolerated in the treatment of GORD
gastroesophageal reflux disease; PPI therapy
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
A-341-x.
2004.
objavljeno
Podaci o matičnoj publikaciji
Gastroenterology
Digestive Disease Week
American Gastroenterological Association
Podaci o skupu
Digestive Disease Week
poster
15.05.2004-20.05.2004
New Orleans (LA), Sjedinjene Američke Države
